Simplex Trading’s XBiotech XBIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.82K Buy
2,900
+1,600
+123% +$3.87K ﹤0.01% 7675
2025
Q4
$3.11K Hold
1,300
﹤0.01% 7674
2025
Q3
$3K Hold
1,300
﹤0.01% 8577
2025
Q2
$3K Buy
+1,300
New +$3.78K ﹤0.01% 8050
2024
Q4
Sell
-400
Closed -$3K 9782
2024
Q3
$3K Sell
400
-600
-60% -$3.94K ﹤0.01% 7909
2024
Q2
$5K Buy
1,000
+100
+11% +$771 ﹤0.01% 7923
2024
Q1
$7K Buy
+900
New +$5.16K ﹤0.01% 7873
2021
Q4
Sell
-2,900
Closed -$47K 11597
2021
Q3
$47K Hold
2,900
﹤0.01% 7573
2021
Q2
$48K Buy
2,900
+2,811
+3,158% +$47.7K ﹤0.01% 7686
2021
Q1
$152K Buy
89
+84
+1,680% +$1.57K ﹤0.01% 5167
2020
Q4
$7K Sell
5
-350
-99% -$6.45K ﹤0.01% 7618
2020
Q3
$677K Sell
355
-3
-0.8% -$52 ﹤0.01% 2677
2020
Q2
$490K Sell
358
-48
-12% -$675 ﹤0.01% 2931
2020
Q1
$431K Buy
406
+304
+298% +$4.95K ﹤0.01% 2755
2019
Q4
$190K Buy
+102
New +$1.31K ﹤0.01% 3824
2019
Q2
Sell
-82
Closed -$90K 7897
2019
Q1
$90K Buy
82
+77
+1,540% +$624 ﹤0.01% 4461
2018
Q4
$2K Sell
5
-45
-90% -$185 ﹤0.01% 6629
2018
Q3
$15K Buy
50
+36
+257% +$140 ﹤0.01% 6195
2018
Q2
$6K Sell
14
-70
-83% -$316 ﹤0.01% 6643
2018
Q1
$6K Buy
84
+59
+236% +$272 ﹤0.01% 4527
2017
Q4
$6K Sell
25
-1
-4% -$4 ﹤0.01% 4390
2017
Q3
$14K Sell
26
-184
-88% -$869 ﹤0.01% 3504
2017
Q2
$139K Sell
210
-77
-27% -$738 0.01% 1484
2017
Q1
$18K Buy
287
+10
+4% +$131 ﹤0.01% 3370
2016
Q4
$92K Buy
277
+107
+63% +$1.42K 0.01% 1607
2016
Q3
$34K Buy
+170
New +$2.49K ﹤0.01% 2463

Other funds holding XBIT

Simplex Trading's XBIT Position: Q1 2026 in Review

Simplex Trading sold out of XBiotech (XBIT) in Q1 2026, closing a stake of 67 shares — an estimated $162 sold.

Simplex Trading first reported a position in XBIT in Q3 2016 and held it in 27 quarters. The position peaked at $295K in Q1 2017. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

  • Simplex Trading reported no remaining XBiotech position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 67 XBiotech shares in Q1 2026, an estimated $162.
  • Simplex Trading first reported a position in XBiotech in Q3 2016 and held it in 27 quarters.
  • Simplex Trading's XBiotech position peaked at $295K in Q1 2017.
  • 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.